Reiner A, Medina L, Haber S N
Department of Anatomy and Neurobiology, The University of Tennessee Health Sciences Center, Memphis, 38163, USA.
Neuroscience. 1999;88(3):775-93. doi: 10.1016/s0306-4522(98)00254-1.
Single- and double-label immunohistochemical techniques using several different highly specific antisera against dynorphin peptides were used to examine the distribution of dynorphinergic terminals in globus pallidus and substantia nigra in rhesus monkeys and humans in comparison to substance P-containing and enkephalinergic terminals in these same regions. Similar results were observed in monkey and human tissue. Dynorphinergic fibers were very abundant in the medial half of the internal pallidal segment, but scarce in the external pallidal segment and the lateral half of the internal pallidal segment. In substantia nigra, dynorphinergic fibers were present in both the pars compacta and reticulata. Labeling of adjacent sections for enkephalin or substance P showed that the dynorphinergic terminals overlapped those for substance P in the medial half of the internal pallidal segment, but showed only slight overlap with enkephalinergic terminals in the external pallidal segment. The substance P-containing fibers were moderately abundant along the borders of the external pallidal segment, and enkephalinergic fibers were moderately abundant in parts of the internal pallidal segment. Dynorphinergic and substance P-containing terminals overlapped extensively in the nigra, and both extensively overlapped enkephalinergic fibers in medial nigra. Immunofluorescence double-labeling studies revealed that dynorphin co-localized extensively with substance P in individual fibers and terminals in the medial half of the internal pallidal segment and in substantia nigra. Thus, as has been found in non-primates, dynorphin within the striatum and its projection systems appears to be extensively localized to substance P-containing striatopallidal and striatonigral projection neurons. Nonetheless, our results also raise the possibility that a population of substance P-containing neurons that projects to the internal pallidal segment and does not contain dynorphin is present in primate striatum. Our results also suggest the possible existence of populations of striatopallidal and striatonigral projection neurons in which substance P and enkephalin or dynorphin and enkephalin, or all three, are co-localized. Thus, striatal projection neurons in primates may not consist of merely two types, one containing substance P and dynorphin and the other enkephalin.
使用几种针对强啡肽肽的不同高特异性抗血清的单标和双标免疫组织化学技术,来检测恒河猴和人类苍白球及黑质中强啡肽能终末的分布,并与这些相同区域中含P物质和脑啡肽能终末进行比较。在猴和人类组织中观察到了相似的结果。强啡肽能纤维在苍白球内侧段的内侧半部非常丰富,但在苍白球外侧段和苍白球内侧段的外侧半部则很少。在黑质中,致密部和网状部均存在强啡肽能纤维。对相邻切片进行脑啡肽或P物质标记显示,强啡肽能终末在苍白球内侧段的内侧半部与含P物质的终末重叠,但在苍白球外侧段仅与脑啡肽能终末有轻微重叠。含P物质的纤维在苍白球外侧段的边界处中等丰富,脑啡肽能纤维在苍白球内侧段的部分区域中等丰富。强啡肽能和含P物质的终末在黑质中广泛重叠,并且两者在内侧黑质中均与脑啡肽能纤维广泛重叠。免疫荧光双标研究显示,在苍白球内侧段的内侧半部和黑质中,强啡肽在单个纤维和终末中与P物质广泛共定位。因此,正如在非灵长类动物中所发现的那样,纹状体内及其投射系统中的强啡肽似乎广泛定位于含P物质的纹状体苍白球和纹状体黑质投射神经元。尽管如此,我们的结果也提出了一种可能性,即灵长类纹状体中存在一群投射到苍白球内侧段且不含强啡肽的含P物质神经元。我们的结果还提示,可能存在纹状体苍白球和纹状体黑质投射神经元群体,其中P物质和脑啡肽或强啡肽和脑啡肽,或三者均共定位。因此,灵长类动物的纹状体投射神经元可能不仅仅由两种类型组成,一种含P物质和强啡肽,另一种含脑啡肽。